NUCLEOLIN and cancer: Chemical modification of 5-(N-benzylcarboxyamide)-2’-deoxyuridine(5-BzdU) in the AS1411-aptamer, which binds to nucleolin in cancer cells, was recently shown to increase binding and targeting affinity to cancer cells [11].